Cisgender gay and bisexual men, transgender women, and transgender men remain at higher risk for HIV acquisition.
Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...
The company recently released phase 3 data showing that a twice-yearly treatment with lenacapavir was 100% effective in HIV ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Doctors and front-line workers are watching closely as HIV rates increase significantly in Alberta.An annual Alberta Health ...
Health NGO, Right to Care, highlights the urgent need for circumcision among boys aged 15 and older in KwaZulu-Natal to ...
"Madagascar’s HIV epidemic is being fueled by gaps in prevention and glaring inequalities, which urgently need to be ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Marine, not her real name, was considering surgery to deal with intense pain. Three doctors refused to see her before a ...
The U.S Food and Drug Administration ( FDA) has confirmed the availability of lenacapavir, a two-yearly injectable HIV/ADS treatment as early as the summer 2025, a decision made by FDA after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback